This single-institution study led by Caroline Townley, PharmD, compares the use of the Onpro device and the manual injection of pegfilgrastim and discusses the potential implications of the findings.
Ákos Juhász, PharmD, and colleagues suggest that the use of a closed-system drug-transfer device would reduce the high levels of contamination found in hospital pharmacies.
In their study, Mark L. Zangardi, PharmD, BCOP, and colleagues, demonstrate that clinical pharmacists have an integral role in the review and approval of off-label oncology treatments.
This pilot study demonstrated that pharmacists in an ambulatory oncology clinic are able to deliver successful tobacco-cessation counseling and interventions for patients with cancer who smoke.
Results 1 - 10 of 50